| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.04 |